50 related articles for article (PubMed ID: 27697329)
1. Bullous pemphigoid associated with psoriasis: a good response to methotrexate.
Vargas P; Giacaman P; Fernández J; Morales C
An Bras Dermatol; 2019; 94(2):224-226. PubMed ID: 31090831
[TBL] [Abstract][Full Text] [Related]
2. Dupilumab for bullous pemphigoid with intractable pruritus.
Seidman JS; Eichenfield DZ; Orme CM
Dermatol Online J; 2019 Nov; 25(11):. PubMed ID: 32045153
[TBL] [Abstract][Full Text] [Related]
3. High-Frequency Color Doppler Sonography of Bullous Pemphigoid: Correlation With Histologic Findings.
Porriño-Bustamante ML; Alfageme F; Suárez L; de Domingo MA; Hospital M; Roustán G
J Ultrasound Med; 2016 Aug; 35(8):1821-5. PubMed ID: 27371374
[TBL] [Abstract][Full Text] [Related]
4. Durability of long-term immunomodulating medications in the treatment of bullous pemphigoid.
Awethe Z; Viveiros M; Kaffenberger J
J Am Acad Dermatol; 2023 Dec; 89(6):1287-1289. PubMed ID: 37595891
[No Abstract] [Full Text] [Related]
5. Anti-laminin γ1 (p200) pemphigoid successfully treated with tofacitinib combined with prednisone.
Zhou X; Zhou Y; Qian H; Wu F; Liu H; Li X; Li W
J Dermatol; 2023 Oct; 50(10):e354-e356. PubMed ID: 37341162
[No Abstract] [Full Text] [Related]
6. Beyond guidelines: the high-dose challenge in severe bullous pemphigoid-a hospital perspective.
Ko EA; Giustozzi MI; Torre AC; Pagotto V; Riganti J; Ruf M; Mazzuoccolo LD
Int J Dermatol; 2024 Apr; 63(4):e86-e88. PubMed ID: 38152861
[No Abstract] [Full Text] [Related]
7. Methotrexate-induced hypersensitivity pneumonitis in a patient with bullous pemphigoid.
Agarwal A; Falcone LM; James AJ
Dermatol Online J; 2023 Aug; 29(4):. PubMed ID: 37921827
[No Abstract] [Full Text] [Related]
8. Meeting Report: ISID2023 Tokyo Satellite Meeting. International Symposium on Autoimmunity Targeting the Skin. -Pemphigus, Pemphigoid, and Beyond.
Yamagami J; Takahashi H; Amagai M
J Dermatol Sci; 2023 Oct; 112(1):2-5. PubMed ID: 37612222
[No Abstract] [Full Text] [Related]
9. Updated French guidelines for the therapeutic management of bullous pemphigoid.
Castel M; Alexandre M; Jelti L; Pham-Ledard A; Viguier M; Bédane C; Tancrède-Bohin E; Musette P; Carvalho P; Cordel N; Caux F; Joly P;
Ann Dermatol Venereol; 2022 Jun; 149(2):81-91. PubMed ID: 34702559
[No Abstract] [Full Text] [Related]
10. Bullous Pemphigoid in Three Paediatric Patients in Finland.
Pankakoski A; Panelius J; Salava A; Kluger N
Acta Derm Venereol; 2020 Mar; 100(6):adv00086. PubMed ID: 32157316
[No Abstract] [Full Text] [Related]
11. Treatment of pemphigus and pemphigoids.
López-Jornet P; Bermejo-Fenoll A
Med Oral Patol Oral Cir Bucal; 2005; 10(5):410-1. PubMed ID: 16264376
[No Abstract] [Full Text] [Related]
12. Failure of initial disease control in bullous pemphigoid: a retrospective study of hospitalized patients in a single tertiary center.
Kremer N; Zeeli T; Sprecher E; Geller S
Int J Dermatol; 2017 Oct; 56(10):1010-1016. PubMed ID: 28856675
[TBL] [Abstract][Full Text] [Related]
13. Bullous pemphigoid treatment review.
Patton T; Korman NJ
Expert Opin Pharmacother; 2006 Dec; 7(17):2403-11. PubMed ID: 17109614
[TBL] [Abstract][Full Text] [Related]
14. Childhood Bullous Pemphigoid: A Treatment Challenge.
Ayala-Cortés AS; Martínez-Cabriales SA; Welsh O; Rosales-Solis G; Vázquez-Martínez O; Ocampo-Candiani J
J Pediatr; 2016 Dec; 179():271-271.e1. PubMed ID: 27697329
[No Abstract] [Full Text] [Related]
15. A retrospective analysis of patients with bullous pemphigoid treated with methotrexate.
Kjellman P; Eriksson H; Berg P
Arch Dermatol; 2008 May; 144(5):612-6. PubMed ID: 18490587
[TBL] [Abstract][Full Text] [Related]
16. Bullous pemphigoid in adolescence.
Patsatsi A; Kyriakou A; Werth VP
Pediatr Dermatol; 2019 Mar; 36(2):184-188. PubMed ID: 30569520
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
